{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:53:26Z","timestamp":1791327206249,"version":"4.3.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08187-x","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:53:31Z","timestamp":1779432811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intratumoral microbiota exhibiting varied responses to neoadjuvant chemotherapy in triple-negative breast cancer revealed by 2bRAD-M"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0038-7009","authenticated-orcid":false,"given":"Ziteng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-8237","authenticated-orcid":false,"given":"Xiangmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"3","key":"8187_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"8187_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, Chen Y. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15(1):121. https:\/\/doi.org\/10.1186\/s13045-022-01341-0.","journal-title":"J Hematol Oncol"},{"issue":"20","key":"8187_CR3","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE. Reis-Filho: Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938\u201348. https:\/\/doi.org\/10.1056\/NEJMra1001389.","journal-title":"N Engl J Med"},{"issue":"2","key":"8187_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.Cd-18-1177","volume":"9","author":"C Garrido-Castro","year":"2019","unstructured":"Garrido-Castro C, Lin NU, Polyak K. Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. for Treatment. Cancer Discov. 2019;9(2):176\u201398. https:\/\/doi.org\/10.1158\/2159-8290.Cd-18-1177.","journal-title":"Cancer Discov"},{"key":"8187_CR5","doi-asserted-by":"publisher","unstructured":"Nedeljkovi\u0107 M, Damjanovi\u0107 A. Mechanisms of chemotherapy resistance in triple-negative breast cancer\u2014how we can rise to the challenge. Cells. 2019;8(9). https:\/\/doi.org\/10.3390\/cells8090957.","DOI":"10.3390\/cells8090957"},{"key":"8187_CR6","doi-asserted-by":"publisher","unstructured":"Hallett RM, Dvorkin-Gheva A, Bane A, Hassell JA. A gene signature for predicting outcome in patients with basal-like breast cancer. Sci Rep. 2012;2:227 https:\/\/doi.org\/10.1038\/srep00227.","DOI":"10.1038\/srep00227"},{"issue":"13","key":"8187_CR7","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/jco.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N, Hwang ES, Khan SA, Loibl S, Morris EA, Perez A, Regan MM, Spears PA, Sudheendra PK, Symmans WF, Yung RL, Harvey BE. Hershman: Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. J Clin Oncol. 2021;39(13):1485\u2013505. https:\/\/doi.org\/10.1200\/jco.20.03399.","journal-title":"J Clin Oncol"},{"issue":"5","key":"8187_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1200\/jco.2007.15.0235","volume":"26","author":"P Rastogi","year":"2008","unstructured":"Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil SR, Tamkus D, King KM, Pajon ER, Wright MJ, Robert J, Paik S, Mamounas EP, Wolmark N. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008;26(5):778\u201385. https:\/\/doi.org\/10.1200\/jco.2007.15.0235.","journal-title":"J Clin Oncol"},{"key":"8187_CR9","doi-asserted-by":"publisher","unstructured":"Lee JS, Yost SE, Yuan Y. Neoadjuvant treatment for triple negative breast cancer: recent progresses and challenges. Cancers (Basel). 2020;12(6). https:\/\/doi.org\/10.3390\/cancers12061404.","DOI":"10.3390\/cancers12061404"},{"issue":"10","key":"8187_CR10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1200\/jco.2015.63.1010","volume":"35","author":"WF Symmans","year":"2017","unstructured":"Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GN. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype. J Clin Oncol. 2017;35(10):1049\u201360. https:\/\/doi.org\/10.1200\/jco.2015.63.1010.","journal-title":"J Clin Oncol"},{"key":"8187_CR11","doi-asserted-by":"publisher","unstructured":"Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, Kuroi K, Im SA, Park BW, Kim SB, Yanagita Y, Ohno S, Takao S, Aogi K, Iwata H, Jeong J, Kim A, Park KH, Sasano H, Ohashi Y, Toi M. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376(22):2147\u20132159. https:\/\/doi.org\/10.1056\/NEJMoa1612645.","DOI":"10.1056\/NEJMoa1612645"},{"issue":"1","key":"8187_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/0115665232283880240301035621","volume":"25","author":"M Araghi","year":"2025","unstructured":"Araghi M, Gharebakhshi F, Faramarzi F, Mafi A, Mousavi T, et al. Efficacy and safety of pembrolizumab monotherapy or combined therapy in patients with metastatic triple-negative breast cancer: a systematic review and meta-analysis of randomized controlled trials. Curr Gene Ther. 2025;25(1):72\u201388. https:\/\/doi.org\/10.2174\/0115665232283880240301035621.","journal-title":"Curr Gene Ther"},{"key":"8187_CR13","doi-asserted-by":"publisher","unstructured":"Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, K\u00fcmmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Untch M, Fasching PA, Cardoso F, Andersen J, Patt D, Danso M, Ferreira M, Mouret-Reynier MA, Im SA, Ahn JH, Gion M, Baron-Hay S, Boileau JF, Ding Y, Tryfonidis K, Aktan G, Karantza V, O\u2019Shaughnessy J. Event-free survival with pembrolizumab in early triple-negative breast cancer. N Engl J Med. 2022;86(6):556\u2013567. https:\/\/doi.org\/10.1056\/NEJMoa2112651.","DOI":"10.1056\/NEJMoa2112651"},{"key":"8187_CR14","doi-asserted-by":"publisher","unstructured":"Schmid P, Cortes J, Pusztai L, McArthur H, K\u00fcmmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Foukakis T, Fasching PA, Cardoso F, Untch M, Jia L, Karantza V, Zhao J, Aktan G, Dent R, O\u2019Shaughnessy J. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382(9):810\u2013821. https:\/\/doi.org\/10.1056\/NEJMoa1910549.","DOI":"10.1056\/NEJMoa1910549"},{"key":"8187_CR15","doi-asserted-by":"publisher","unstructured":"Jin H, Wan M, Pan S, Wang Z, Wang W, et al. CD1B expression in triple-negative breast cancer: its implications for prognosis and immunotherapy outcomes. Curr Gene Ther. 2025. Advance online publication. https:\/\/doi.org\/10.2174\/0115665232364481250131071311.","DOI":"10.2174\/0115665232364481250131071311"},{"issue":"10","key":"8187_CR16","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/0008-5472.Can-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li Y, Zhai E, Zhao R, Qian Y, Huang Z, Liu Y, Zhao Z, Xu X, Liu J, Li Z, Liang Z, Wei R, Ye L, Ma J, Wu Q, Chen J, Cai S. Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion. Cancer Res. 2025;85(10):1819\u201341. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-2580.","journal-title":"Cancer Res"},{"key":"8187_CR17","doi-asserted-by":"publisher","first-page":"114677","DOI":"10.1016\/j.intimp.2025.114677","volume":"156","author":"J Cai","year":"2025","unstructured":"Cai J, Zhang W, Zhu S, Lin T, Mao R, Wu N, Zhang P, Kang M. Gut and Intratumoral microbiota: Key to lung Cancer development and immunotherapy. Int Immunopharmacol. 2025;156:114677. https:\/\/doi.org\/10.1016\/j.intimp.2025.114677.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"8187_CR18","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s12094-024-03757-1","volume":"27","author":"T Jing","year":"2025","unstructured":"Jing T, Tang D. Intratumoral microbiota: a new force in the development and treatment of esophageal cancer. Clin Transl Oncol. 2025;27(5):1921\u201332. https:\/\/doi.org\/10.1007\/s12094-024-03757-1.","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"8187_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.chom.2025.04.003","volume":"33","author":"J Yu","year":"2025","unstructured":"Yu J, Liang Y, Zhang Q, Ding H, Xie M, Zhang J, Hu W, Xu S, Xiao Y, Xu S, Na R, Wu B, Zhou J, Chen H. An interplay between human genetics and intratumoral microbiota in the progression of colorectal cancer. Cell Host Microbe. 2025;33(5):657\u2013e6706. https:\/\/doi.org\/10.1016\/j.chom.2025.04.003.","journal-title":"Cell Host Microbe"},{"key":"8187_CR20","doi-asserted-by":"publisher","first-page":"1574511","DOI":"10.3389\/fcimb.2025.1574511","volume":"15","author":"Y Guo","year":"2025","unstructured":"Guo Y, Xiao Y, Zhang C, Wang Y, Cao G, Tse KY, Han Z, Li F, Zhi Y. The intratumoral microbiota heterogenicity is related to the prognosis and tumorigenesis of cervical cancer. Front Cell Infect Microbiol. 2025;15:1574511. https:\/\/doi.org\/10.3389\/fcimb.2025.1574511.","journal-title":"Front Cell Infect Microbiol"},{"key":"8187_CR21","doi-asserted-by":"publisher","unstructured":"Gnanasekaran J, Binder Gallimidi A, Saba E, Pandi K, Eli Berchoer L, Hermano E, Angabo S, Makkawi HA, Khashan A, Daoud A, Elkin M. Nussbaum. Intracellular porphyromonas gingivalis promotes the tumorigenic behavior of pancreatic carcinoma cells. Cancers (Basel). 2020;12(8). https:\/\/doi.org\/10.3390\/cancers12082331.","DOI":"10.3390\/cancers12082331"},{"issue":"1","key":"8187_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40425-018-0490-z","volume":"7","author":"V Raman","year":"2019","unstructured":"Raman V, Van Dessel N, O\u2019Connor OM, Forbes NS. The motility regulator flhDC drives intracellular accumulation and tumor colonization of Salmonella. J Immunother Cancer. 2019;7(1):44. https:\/\/doi.org\/10.1186\/s40425-018-0490-z.","journal-title":"J Immunother Cancer"},{"key":"8187_CR23","doi-asserted-by":"publisher","unstructured":"Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y, Gao R, Liu M, Yin M, Pan C, Li H, Guo B, Zhu Q, Wei Q, Moyer MP, Wang P, Cai S, Goel A, Qin H, Ma Y. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signalling to nuclear factor-\u03baB, and up-regulating expression of microRNA-21. Gastroenterology. 2017:152(4):851\u2013866.e24. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.018.","DOI":"10.1053\/j.gastro.2016.11.018"},{"key":"8187_CR24","doi-asserted-by":"publisher","first-page":"1301506","DOI":"10.3389\/fimmu.2023.1301506","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu J, Zhang P, Mei W, Zeng C. Intratumoral microbiota: implications for cancer onset, progression, and therapy. Front Immunol. 2023;14:1301506. https:\/\/doi.org\/10.3389\/fimmu.2023.1301506.","journal-title":"Front Immunol"},{"key":"8187_CR25","doi-asserted-by":"publisher","unstructured":"Laborda-Illanes L, Aranega-Mart\u00edn L, S\u00e1nchez-Alcoholado S, Boutriq I, Plaza-Andrades J, Peralta-Linero G, Garrido Ruiz B, Pajares- Hachero M, \u00c1lvarez E, Alba A, Gonz\u00e1lez-Gonz\u00e1lez. Queipo-Ortu\u00f1o. Exploring the relationship between microRNAs, intratumoral microbiota and breast cancer progression in patients with and without metastasis. Int J Mol Sci. 2024;25(13). https:\/\/doi.org\/10.3390\/ijms25137091.","DOI":"10.3390\/ijms25137091"},{"issue":"8","key":"8187_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.tim.2024.01.007","volume":"32","author":"YQ Lu","year":"2024","unstructured":"Lu YQ, Qiao H, Tan XR, Liu N. Broadening oncological boundaries: the intratumoral microbiota. Trends Microbiol. 2024;32(8):807\u201322. https:\/\/doi.org\/10.1016\/j.tim.2024.01.007.","journal-title":"Trends Microbiol"},{"issue":"6","key":"8187_CR27","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.21873\/anticanres.17035","volume":"44","author":"CM Chang","year":"2024","unstructured":"Chang CM, Pekkle Lam HY. Intratumoral Microbiota: Unraveling their Oncogenic Impact on Cancer Progression with Focus on Breast Cancer Therapeutic Outcomes. Anticancer Res. 2024;44(6):2271\u201385. https:\/\/doi.org\/10.21873\/anticanres.17035.","journal-title":"Anticancer Res"},{"key":"8187_CR28","doi-asserted-by":"publisher","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, Meltser A, Douglas GM, Kamer I, Gopalakrishnan V, Dadosh T, Levin-Zaidman S, Avnet S, Atlan T, Cooper ZA, Arora R, Cogdill AP, Khan MAW, Ologun G, Bussi Y, Weinberger A, Lotan-Pompan M, Golani O, Perry G, Rokah M, Bahar-Shany K, Rozeman EA, Blank CU, Ronai A, Shaoul R, Amit A, Dorfman T, Kremer R, Cohen ZR, Harnof S, Siegal T, Yehuda-Shnaidman E, Gal-Yam EN, Shapira H, Baldini N, Langille MGI, Ben-Nun A, Kaufman B, Nissan A, Golan T, Dadiani M, Levanon K, Bar J, Yust-Katz S, Barshack I, Peeper DS, Raz DJ, Segal E, Wargo JA. J. Sandbank, N. Shental, Straussman R. The human tumor microbiome is composed of tumor-associated microorganisms. microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368(6494):973\u2013980. https:\/\/doi.org\/10.1126\/science.aay9189.","DOI":"10.1126\/science.aay9189"},{"key":"8187_CR29","doi-asserted-by":"publisher","first-page":"30751","DOI":"10.1038\/srep30751","volume":"6","author":"TJ Hieken","year":"2016","unstructured":"Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, Xiao J, Radisky DC, Knutson KL, Kalari KR, Yao JZ, Baddour LM, Chia N. Degnim: The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease. sci Rep. 2016;6:30751. https:\/\/doi.org\/10.1038\/srep30751.","journal-title":"sci Rep"},{"issue":"10","key":"8187_CR30","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1128\/aem.00242-14","volume":"80","author":"C Urbaniak","year":"2014","unstructured":"Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, Scott L, O\u2019Hanlon DM, Burton JP, Francis KP, Tangney M, Reid G. Microbiota of human breast tissue. Appl Environ Microbiol. 2014;80(10):3007\u201314. https:\/\/doi.org\/10.1128\/aem.00242-14.","journal-title":"Appl Environ Microbiol"},{"key":"8187_CR31","doi-asserted-by":"publisher","first-page":"100786","DOI":"10.1016\/j.neo.2022.100786","volume":"27","author":"TJ Hieken","year":"2022","unstructured":"Hieken TJ, Chen J, Chen B, Johnson S, Hoskin TL, Degnim AC, Walther-Antonio MR, Chia N. The breast tissue microbiome, stroma, immune cells and breast cancer. Neoplasia. 2022;27:100786. https:\/\/doi.org\/10.1016\/j.neo.2022.100786.","journal-title":"Neoplasia"},{"issue":"8","key":"8187_CR32","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"B Fu","year":"2022","unstructured":"Fu B, Yao T, Dong Y, Chen J, Yao Y, Liu H, Li H, Bai X, Liu Y, Zhang C, Wang Y, Guo N, Li, Cai S. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185(8):1356\u2013e137226. https:\/\/doi.org\/10.1016\/j.cell.2022.02.027.","journal-title":"Cell"},{"issue":"8","key":"8187_CR33","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.cell.2022.03.013","volume":"185","author":"GD Longmore","year":"2022","unstructured":"Longmore GD. Bacteria in tumors hit the road together. Cell. 2022;185(8):1292\u20134. https:\/\/doi.org\/10.1016\/j.cell.2022.03.013.","journal-title":"Cell"},{"issue":"1","key":"8187_CR34","doi-asserted-by":"publisher","first-page":"16893","DOI":"10.1038\/s41598-018-35329-z","volume":"8","author":"L Costantini","year":"2018","unstructured":"Costantini L, Magno S, Albanese D, Donati C, Molinari R, Filippone A, Masetti R, Merendino N. Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions. Sci Rep. 2018;8(1):16893. https:\/\/doi.org\/10.1038\/s41598-018-35329-z.","journal-title":"Sci Rep"},{"issue":"4","key":"8187_CR35","doi-asserted-by":"publisher","first-page":"e010365","DOI":"10.1136\/jitc-2024-010365","volume":"13","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yang L, Huang Y, Zhu T, Zhang L, et al. Intratumoral microbiota predicts the response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer. J Immunother Cancer. 2025;13(4):e010365. https:\/\/doi.org\/10.1136\/jitc-2024-010365.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"8187_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/procel\/pwae005","volume":"15","author":"W Ma","year":"2024","unstructured":"Ma W, Zhang L, Chen W, Chang Z, Tu J, et al. Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1. Protein Cell. 2024;15(6):419\u201340. https:\/\/doi.org\/10.1093\/procel\/pwae005.","journal-title":"Protein Cell"},{"key":"8187_CR37","doi-asserted-by":"publisher","first-page":"1169101","DOI":"10.3389\/fcimb.2023.1169101","volume":"13","author":"Y Hou","year":"2023","unstructured":"Hou Y, Zhang M, Jiang Q, Yang Y, Liu J, et al. Microbial signatures of neonatal bacterial meningitis from multiple body sites. Front Cell Infect Microbiol. 2023;13:1169101. https:\/\/doi.org\/10.3389\/fcimb.2023.1169101.","journal-title":"Front Cell Infect Microbiol"},{"key":"8187_CR38","doi-asserted-by":"publisher","first-page":"1231354","DOI":"10.3389\/fmicb.2023.1231354","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, Zheng Y, Chen X, Peng C, Zhou S, Shen S, Zhao S, Wang T. 2bRAD-M reveals the difference in microbial distribution between cancerous and benign ovarian tissues. Front Microbiol. 2023;14:1231354. https:\/\/doi.org\/10.3389\/fmicb.2023.1231354.","journal-title":"Front Microbiol"},{"key":"8187_CR39","doi-asserted-by":"publisher","first-page":"871017","DOI":"10.3389\/fmicb.2022.871017","volume":"13","author":"T Lam","year":"2022","unstructured":"Lam T, Chew D, Zhao H, Zhu P, Zhang L, Dai Y, Liu J, Xu J. Species-Resolved Metagenomics of Kindergarten Microbiomes Reveal Microbial Admixture Within Sites and Potential Microbial Hazards. Front Microbiol. 2022;13:871017. https:\/\/doi.org\/10.3389\/fmicb.2022.871017.","journal-title":"Front Microbiol"},{"issue":"1","key":"8187_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13059-021-02576-9","volume":"23","author":"Z Sun","year":"2022","unstructured":"Sun Z, Huang S, Zhu P, Tzehau L, Zhao H, Lv J, Zhang R, Zhou L, Niu Q, Wang X, Zhang M, Jing G, Bao Z, Liu J, Wang S, Xu J. Species-resolved sequencing of low-biomass Microbial Hazards. sequencing of low-biomass or degraded microbiomes using 2bRAD-M. Genome Biol. 2022;23(1):36. https:\/\/doi.org\/10.1186\/s13059-021-02576-9.","journal-title":"Genome Biol"},{"issue":"2","key":"8187_CR41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/jb.173.2.697-703.1991","volume":"173","author":"WG Weisburg","year":"1991","unstructured":"Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 1991;173(2):697\u2013703. https:\/\/doi.org\/10.1128\/jb.173.2.697-703.1991.","journal-title":"J Bacteriol"},{"key":"8187_CR42","doi-asserted-by":"publisher","unstructured":"Tripathi D, Davies NM, Rajinikanth PS, Pandey P. Advancements in targeted therapies and pharmacogenomics for personalized breast cancer treatment: The role of gene SNPs in treatment resistance. Curr Gene Ther. 2025. Advance online publication. https:\/\/doi.org\/10.2174\/0115665232373621250618181424.","DOI":"10.2174\/0115665232373621250618181424"},{"key":"8187_CR43","doi-asserted-by":"publisher","first-page":"e18761429263841","DOI":"10.2174\/0118761429263841230926014118","volume":"17","author":"Y Naeimzadeh","year":"2024","unstructured":"Naeimzadeh Y, Heidari Z, Razban V, Khajeh S. Deregulated MicroRNAs involved in P53 signaling pathway in breast cancer with focus on triple-negative breast cancer. Curr Mol Pharmacol. 2024;17:e18761429263841. https:\/\/doi.org\/10.2174\/0118761429263841230926014118.","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"8187_CR44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10549-020-05580-y","volume":"180","author":"M Iwase","year":"2020","unstructured":"Iwase M, Ando M, Aogi K, Aruga T, Inoue K, Shimomura A, Tokunaga E, Masuda N, Yamauchi H, Yamashita T, Iwata H. Long-term survival analysis of the addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer. Breast Cancer Res Treat. 2020;180(3):687\u201394. https:\/\/doi.org\/10.1007\/s10549-020-05580-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"8187_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13058-025-01994-y","volume":"27","author":"M Li","year":"2025","unstructured":"Li M, Zhou S, Lv H, Cai M, Shui R, Yang W. Neoadjuvant chemotherapy response in androgen receptor-positive triple-negative breast cancer. Potential predictive biomarkers and genetic alterations. Breast Cancer Res. 2025;27(1):41. https:\/\/doi.org\/10.1186\/s13058-025-01994-y.","journal-title":"Breast Cancer Res"},{"issue":"13","key":"8187_CR46","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1007\/s00259-023-06394-y","volume":"50","author":"RD Seban","year":"2023","unstructured":"Seban RD, Arnaud E, Loirat D, Cabel L, Cottu P, Djerroudi L, Hescot S, Loap P, Bonneau C, Bidard FC, Huchet V, Jehanno N, Berenbaum A, Champion L, Buvat I. [18F]FDG PET\/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab. Eur J Nucl Med Mol Imaging. 2023;50(13):4024\u201335. https:\/\/doi.org\/10.1007\/s00259-023-06394-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"8187_CR47","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12967-025-06369-7","volume":"23","author":"Y Chen","year":"2025","unstructured":"Chen Y, Huang Y, Li W, Zhu T, Cheng M, Wu C, Zhang L, Peng H, Wang K. Intratumoral microbiota-aided fusion radiomics model for predicting tumor response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer. J Transl Med. 2025;23(1):352. https:\/\/doi.org\/10.1186\/s12967-025-06369-7.","journal-title":"J Transl Med"},{"issue":"1","key":"8187_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12967-023-03938-6","volume":"21","author":"Y He","year":"2023","unstructured":"He Y, Zhang Q, Yu X, Zhang S, Guo W. Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues. J Translational Med. 2023;21(1):68. https:\/\/doi.org\/10.1186\/s12967-023-03938-6.","journal-title":"J Translational Med"},{"issue":"1","key":"8187_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12967-024-05036-7","volume":"22","author":"C Xue","year":"2024","unstructured":"Xue C, Gu X, Shi Q, Ma X, Jia J, et al. The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma. J Translational Med. 2024;22(1):237. https:\/\/doi.org\/10.1186\/s12967-024-05036-7.","journal-title":"J Translational Med"},{"issue":"10\u201311","key":"8187_CR50","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/carcin\/bgad071","volume":"44","author":"S Actis","year":"2023","unstructured":"Actis S, Cazzaniga M, Bounous VE, D\u2019Alonzo M, Rosso R, Accomasso F, Minella C, Biglia N. Emerging evidence on the role of breast microbiota on the development of breast cancer in high-risk patients. Carcinogenesis. 2023;44(10\u201311):718\u201325. https:\/\/doi.org\/10.1093\/carcin\/bgad071.","journal-title":"Carcinogenesis"},{"key":"8187_CR51","doi-asserted-by":"publisher","unstructured":"Desalegn Z, Smith A, Yohannes M, Cao X, Anberber E, Bekuretsion Y, Assefa M, Bauer M, Vetter M, Kantelhardt EJ, Abebe T. Starlard- Davenport. Human breast tissue microbiota reveals unique microbial signatures that correlate with prognostic features in adult Ethiopian women with breast cancer. Cancers (Basel). 2023;15(19). https:\/\/doi.org\/10.3390\/cancers15194893.","DOI":"10.3390\/cancers15194893"},{"issue":"15","key":"8187_CR52","doi-asserted-by":"publisher","first-page":"7494","DOI":"10.1002\/jsfa.12836","volume":"103","author":"X Lu","year":"2023","unstructured":"Lu X, Zhang M, Ma Y, Li G, Zhao X, Qian W. Protective effect of Limosilactobacillus reuteri-fermented yogurt on mouse intestinal barrier injury induced by enterotoxigenic Escherichia coli. J Sci Food Agric. 2023;103(15):7494\u2013505. https:\/\/doi.org\/10.1002\/jsfa.12836.","journal-title":"J Sci Food Agric"},{"issue":"4","key":"8187_CR53","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/carcin\/bgad086","volume":"45","author":"H Yang","year":"2024","unstructured":"Yang H, Li S, Li W, Yang Y, Zhang Y, Zhang S, Hao Y, Cao W, Xu F, Wang H, Du G, Wang J. Actinomycin D synergizes with Doxorubicin in triple- negative breast cancer by inducing P53-dependent cell apoptosis. Carcinogenesis. 2024;45(4):262\u201373. https:\/\/doi.org\/10.1093\/carcin\/bgad086.","journal-title":"Carcinogenesis"},{"key":"8187_CR54","doi-asserted-by":"publisher","unstructured":"Lin SQ, Jia FJ, Zhang CY, Liu FY, Ma JH, Han Z, Xie WD, Li X. Actinomycin V suppresses human non-small-cell lung carcinoma A549 cells by inducing G2\/M phase arrest and apoptosis via the p53-dependent pathway. Mar Drugs. 2019;17(10). https:\/\/doi.org\/10.3390\/md17100572.","DOI":"10.3390\/md17100572"},{"issue":"1","key":"8187_CR55","doi-asserted-by":"publisher","first-page":"e20230316","DOI":"10.1590\/1678-4685-gmb-2023-0316","volume":"47","author":"V D\u2019Afonseca","year":"2024","unstructured":"D\u2019Afonseca V, Mu\u00f1oz EV, Leal AL, Soto P, Parra-Cid C. Implications of the microbiome and metabolic intermediaries produced by bacteria in breast cancer. Genet Mol Biol. 2024;47(1):e20230316. https:\/\/doi.org\/10.1590\/1678-4685-gmb-2023-0316.","journal-title":"Genet Mol Biol"},{"key":"8187_CR56","doi-asserted-by":"publisher","unstructured":"Bernardo G, Le Noci V, Di Modica M, Montanari E, Triulzi T, Pupa SM, Tagliabue E, Sommariva M, Sfondrini L. The emerging role of the microbiota in breast cancer progression. Cells. 2023;12(15). https:\/\/doi.org\/10.3390\/cells12151945.","DOI":"10.3390\/cells12151945"},{"key":"8187_CR57","doi-asserted-by":"publisher","first-page":"1552010","DOI":"10.3389\/fimmu.2025.1552010","volume":"16","author":"D Li","year":"2025","unstructured":"Li D, Lan X, Xu L, Zhou S, Luo H, et al. Influence of gut microbial metabolites on tumor immunotherapy: Mechanisms and potential natural products. Front Immunol. 2025;16:1552010. https:\/\/doi.org\/10.3389\/fimmu.2025.1552010.","journal-title":"Front Immunol"},{"issue":"3","key":"8187_CR58","doi-asserted-by":"publisher","first-page":"667","DOI":"10.34172\/apb.025.45431","volume":"15","author":"P Khanicheragh","year":"2025","unstructured":"Khanicheragh P, Biray Avci \u00c7, Abbasi-Malati Z, et al. Toll-Like Receptor-4 Signaling Pathway Influenced the Exosome Biogenesis and Angiogenesis in Human Triple-Negative Breast Cancer Cells. Adv Pharm Bull. 2025;15(3):667\u201377. https:\/\/doi.org\/10.34172\/apb.025.45431. Published 2025 Aug 31.","journal-title":"Adv Pharm Bull"},{"key":"8187_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.vetmic.2018.10.031","volume":"227","author":"B Li","year":"2018","unstructured":"Li B, Xi P, Wang Z, Han X, Xu Y, et al. PI3K\/Akt\/mTOR signaling pathway participates in Streptococcus uberis-induced inflammation in mammary epithelial cells in concert with the classical TLRs\/NF-\u0138B pathway. Vet Microbiol. 2018;227:103\u201311. https:\/\/doi.org\/10.1016\/j.vetmic.2018.10.031.","journal-title":"Vet Microbiol"},{"issue":"6","key":"8187_CR60","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","volume":"28","author":"KD Courtney","year":"2010","unstructured":"Courtney KD, Corcoran RB, Engelman JA. The PI3K pathway as drug target in human cancer. J Clin Oncol. 2010;28(6):1075\u201383. https:\/\/doi.org\/10.1200\/JCO.2009.25.3641.","journal-title":"J Clin Oncol"},{"issue":"7","key":"8187_CR61","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/1878-0261.12975","volume":"16","author":"T Wilkie","year":"2022","unstructured":"Wilkie T, Verma AK, Zhao H, Charan M, Ahirwar DK, Kant S, Pancholi V, Mishra S, Ganju RK. Lipopolysaccharide from the commensal microbiota of the breast enhances cancer growth: role of S100A7 and TLR4. Mol Oncol. 2022;16(7):1508\u201322. https:\/\/doi.org\/10.1002\/1878-0261.12975.","journal-title":"Mol Oncol"},{"issue":"3","key":"8187_CR62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szak\u00e1cs","year":"2006","unstructured":"Szak\u00e1cs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discovery. 2006;5(3):219\u201334. https:\/\/doi.org\/10.1038\/nrd1984.","journal-title":"Nat Rev Drug Discovery"},{"key":"8187_CR63","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.3","volume":"39","author":"SV Ambudkar","year":"1999","unstructured":"Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol. 1999;39:361\u201398. https:\/\/doi.org\/10.1146\/annurev.pharmtox.39.1.3.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"8187_CR64","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1128\/EC.3.4.1062-1065.2004","volume":"3","author":"M Kruppa","year":"2004","unstructured":"Kruppa M, Krom BP, Chauhan N, Bambach AV, Cihlar RL, et al. The two-component signal transduction protein Chk1p regulates quorum sensing in Candida albicans. Eukaryot Cell. 2004;3(4):1062\u20135. https:\/\/doi.org\/10.1128\/EC.3.4.1062-1065.2004.","journal-title":"Eukaryot Cell"},{"issue":"10","key":"8187_CR65","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1128\/JB.187.10.3407-3414.2005","volume":"187","author":"HC Lai","year":"2005","unstructured":"Lai HC, Soo PC, Wei JR, Yi WC, Liaw SJ, et al. The RssAB two-component signal transduction system in Serratia marcescens regulates swarming motility and cell envelope architecture in response to exogenous saturated fatty acids. J Bacteriol. 2005;187(10):3407\u201314. https:\/\/doi.org\/10.1128\/JB.187.10.3407-3414.2005.","journal-title":"J Bacteriol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08187-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08187-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08187-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:19:40Z","timestamp":1784182780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08187-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8187"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08187-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involved in the use of human samples was conducted in accordance with the Declaration of Helsinki. This study protocol was approved by the Ethical Review Board of the Fourth Hospital of Hebei Medical University (approval number: [2017016]), and the Tangshan People\u2019s Hospital (approval number: [RMYY-LLKS-2020-21]). All participants provided written informed consent prior to their inclusion in the study.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this paper. The research was conducted independently, and the results presented in this study are the sole responsibility of the authors.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"922"}}